Article

Cost Implications of Pertuzumab/Trastuzumab Combination

In this segment, panelists address coverage strategies health plans may utilize to finance patient access to the combination treatment.

Related Videos
John Barkett, MBA
John Barkett, MBA
John Barkett, MBA
Tom Belmont
Dr Mingyang Song
John Michael O'Brien, PharmD, MPH
Dr Kimlin Tam Ashing
H. John Beardsley, MBA, and Fauzea Hussain, MPH, sitting for a video interview
Dr Kimlin Tam Ashing
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo